Lactulose
Rank #393 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$23.6M
Total Cost
538,677
Total Claims
$23.6M
Total Cost
18,562
Prescribers
$44
Cost per Claim
95,530
Beneficiaries
594,051
30-Day Fills
$1,273
Avg Cost/Provider
29
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$23.6M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $23.6M total
Top Prescribers of Lactulose
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Rozaliya Ostrovskaya | Internal Medicine | Brooklyn, NY | 150 | $315K |
| 2 | Ricky Lockett | Physical Medicine and Rehabilitation | Saint Petersburg, FL | 110 | $236K |
| 3 | Amr Nayel | Family Practice | Astoria, NY | 53 | $226K |
| 4 | Vlad Nusinovich | Internal Medicine | West Hollywood, CA | 193 | $219K |
| 5 | Sekar Natarajan | Internal Medicine | Jersey City, NJ | 66 | $199K |
| 6 | Jeffrey Hyman | Internal Medicine | Brooklyn, NY | 32 | $167K |
| 7 | Tauqeer Ahmad | Family Practice | Staten Island, NY | 67 | $156K |
| 8 | Xiandong Shi | Internal Medicine | Flushing, NY | 79 | $155K |
| 9 | Oksana Berkovich | Internal Medicine | Bronx, NY | 61 | $148K |
| 10 | Rena Khanukayeva | Family Practice | Staten Island, NY | 29 | $140K |
| 11 | Ayodele Atolagbe | Family Practice | Jamaica, NY | 67 | $135K |
| 12 | Joven Dungo | Internal Medicine | Jersey City, NJ | 21 | $128K |
| 13 | Ilya Rachman | Internal Medicine | Reseda, CA | 102 | $124K |
| 14 | Adegboyega Adebayo | Internal Medicine | New York, NY | 38 | $123K |
| 15 | Peter Aline | Internal Medicine | Oxnard, CA | 72 | $114K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 390 | Fenofibrate (Fenofibrate) | $24.2M | 670,936 |
| 391 | Empaglifloz/Linaglip/Metformin (Trijardy Xr) | $23.9M | 28,001 |
| 392 | Fluticasone Furoate (Arnuity Ellipta) | $23.7M | 74,825 |
| 393 | Lactulose (Lactulose) | $23.6M | 538,677 |
| 394 | Siponimod (Mayzent) | $23.5M | 2,195 |
| 395 | Droxidopa (Droxidopa) | $23.4M | 9,058 |
| 396 | Fenofibrate Nanocrystallized (Fenofibrate) | $23.2M | 602,181 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology